Primary immunodeficiency (PID) is a group of genetically determined disorders characterized by inadequate immune function. These diseases lead to increased susceptibility of the body to infections, as well as to autoimmune and oncological manifestations. PID can be caused by various genetic defects affecting both cellular and humoral immunity. Clinical manifestations of PID include frequent and severe infections, chronic respiratory diseases, and tumor activity. Diagnosis and treatment of PID continue to be relevant tasks for specialists in the field of immunology and allergology.
History of the disease and interesting historical facts
The first case of primary immunodeficiency was described in the scientific literature in 1965, when Dr. B. A. Munger and his colleagues identified a girl with an autosomal recessive syndrome with a combination of agammaglobulinemia and frequent infections. This opened a new field of medicine devoted to the study of immune system disorders. Interesting facts include that many of the mutations that cause PIDs were first identified in recent decades due to advances in molecular biology and genetic research. In the 2000s, newborn screening programs for inherited immunodeficiencies have become widespread, allowing physicians to identify and treat them early. The introduction of gene therapy in the early 2000s has provided hope for a cure for some forms of PID, the most well-known of which was transformed by adenosine deaminase (ADA) disease therapy.
Epidemiology
The epidemiology of primary immunodeficiency is quite diverse and varies by region. According to the World Health Organization, the prevalence of PID is approximately 1 in 100,000 population. It is estimated that more than 400 different forms of PID have already been described. The most common forms are agammaglobulinemia, selective IgA deficiency, and Down syndrome. Despite the relative rarity, it should be noted that the incidence in certain populations, such as neonates or individuals with a family history of PID, may be significantly increased.
Genetic predisposition to this disease
Genetic predisposition to primary immunodeficiency is associated with various mutations in genes responsible for the development and function of immune system cells. These genes include, for example, genes encoding proteins involved in the production of antibodies (e.g., immunoglobulin genes), as well as genes responsible for the development of T cells and macrophages. Studies have shown that more than 300 different mutations can lead to various forms of PID, including defects in modulators such as CD40L and RAG1/RAG2, which has sparked interest in further research and the development of treatments aimed at restoring normal immune function.
Risk factors for the development of this disease
Risk factors for primary immunodeficiency can be both genetic and exogenous. The main risk factors include:
- Heredity: Having a family history of PID can significantly increase your chances of developing the disease.
- Gender: Many forms of PID, such as Lynch syndrome, are more common in men.
- Ethnicity: Some genetic changes that cause PID may be more common in certain ethnic groups.
- Environmental factors: Exposure to certain chemicals and viruses early in life may cause or worsen susceptibility to disease.
Diagnosis of this disease
Diagnosis of primary immunodeficiency begins with a clinical examination and anamnesis, where the main symptoms may be:
- Frequent and recurring infections, especially of the respiratory and genitourinary tracts.
- Detection of purulent infections including pneumonia, meningitis and abscesses.
- Delay in development or growth.
Basic laboratory tests include:
- Measurement of immunoglobulin levels in blood serum.
- Total number and functionality of T and B lymphocytes.
- Genetic testing for mutations that cause PID.
Radiological tests such as chest x-rays may be used to evaluate respiratory function, and other diagnostic tests, including the use of small markers in genetic testing, may be used to identify more specific forms of PID.
Differential diagnosis must include other types of immunodeficiency, including secondary immunodeficiency caused by infections or therapies such as chemotherapy.
Treatment
Treatment of primary immunodeficiency depends on its form and severity of the clinical picture. The main areas of therapy include:
- Immunoglobulin therapy, which is often used to replenish antibody deficiency.
- Pharmacological treatment to control infections, including antibiotics and antifungals.
- Surgery may be indicated in the presence of certain conditions, such as abscesses or immune system defects.
- Gene therapy, which is becoming increasingly important for specific forms of PID, is designed to correct or replace faulty genes.
List of medications used to treat this disease
The main drugs used to treat primary immunodeficiency include:
- Immunoglobulins: IVIG (intravenous) and SCIG (subcutaneous).
- Antibiotics: amoxicillin, cephalexin and others, for the prevention and treatment of infections.
- Antifungal drugs: fluconazole and others, depending on the type of infection.
Disease monitoring
Disease monitoring is an integral part of primary immunodeficiency treatment, including monitoring immunoglobulin levels, regular testing for infections, and early management of complications. Prognosis depends largely on the severity of the disease and the cumulative impact of therapy on the patient. Complications may include chronic infections, development of autoimmune processes, and malignancy.
Age-related features of the disease
Age-related features of primary immunodeficiency manifest themselves in different clinical manifestations and perception of infection in newborns, children and adults. In newborns, PID can manifest itself in the form of severe infections from the first months of life, while in adults, symptoms can develop gradually, with the first manifestation at a later age. Children are characterized by more frequent respiratory infections, while in the elderly, autoimmune disorders and cases of cancer can be observed.
Questions and Answers
- What is primary immunodeficiency?
Primary immunodeficiency is a group of genetically determined diseases that result in inadequate immune system function and increased susceptibility to infections. - How is PID diagnosed?
Diagnosis of PID includes clinical examination, laboratory tests for immunoglobulin levels, and genetic testing. - What are the treatments for PID?
Treatment includes immunoglobulins, antibiotics, antifungal drugs and, in some cases, surgery or gene therapy. - What risk factors predispose to PID?
Heredity, gender, ethnicity, and environmental exposures may increase the risk of developing PID. - What is the prognosis for patients with PID?
The prognosis depends on the form of the disease and its control, but with timely treatment, many patients can lead a full life.
